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ABSTRACT
Objective To compare the effectiveness of an algorithm for
diagnosis of active labour in primiparous women with
standard care in terms of maternal and neonatal
outcomes.
Design Cluster randomised trial.
SettingMaternity units in Scotland with at least 800
annual births.
Participants 4503 women giving birth for the first time, in
14maternity units. Seven experimental clusters collected
data from a baseline sample of 1029 women and a post-
implementation sample of 896 women. The seven control
clusters had a baseline sample of 1291 women and a
post-implementation sample of 1287 women.
Intervention Use of an algorithm by midwives to assist
their diagnosis of active labour, compared with standard
care.
Main outcomes Primary outcome: use of oxytocin for
augmentation of labour. Secondary outcomes: medical
interventions in labour, admission management, and
birth outcome.
Results No significant difference was found between
groups in percentage use of oxytocin for augmentation of
labour (experimental minus control, difference=0.3, 95%
confidence interval −9.2 to 9.8; P=0.9) or in the use of
medical interventions in labour. Women in the algorithm
group were more likely to be discharged from the labour
suite after their first labour assessment (difference=
−19.2, −29.9 to −8.6; P=0.002) and to have more pre-
labour admissions (0.29, 0.04 to 0.55; P=0.03).
Conclusions Use of an algorithm to assist midwives with
the diagnosis of active labour in primiparous women did
not result in a reduction in oxytocin use or in medical
intervention in spontaneous labour. Significantly more
women in the experimental group were discharged home
after their first labour ward assessment.
Trial registration Current Controlled Trials
ISRCTN00522952.
INTRODUCTION
Women are often uncertain about the onset of labour
and timing their hospital admission,1-4 and this
uncertainty may also extend to midwives and
obstetricians. Although superficially straightforward,
diagnosis of labour has been described as one of the
most difficult and important judgments in the care of a
woman in labour.5 Evidence shows that misjudgments
are often made: between 30% and 45% of women
admitted to labour wards in the United Kingdom and
other developed countries are subsequently found not
to be in labour.6-8 These admissions may have
important clinical consequences. Several studies have
shown that women admitted in the latent phase or not
yet in labour are more likely to receive medical
intervention (electronic monitoring, epidural analge-
sia, oxytocin, and caesarean section) than those
admitted in active labour.8-11 The widespread use of
routine medical intervention in labour is of worldwide
concern.12-15 Caesarean section rates as high as 80%
have been reported among some groups.16 In England,
only 46% of women experience normal birth—that is,
birth without surgical intervention, use of instruments,
induction, augmentation with oxytocin, epidural, or
general anaesthetic.17 Interventions in labour have
been associated with increased levels of morbidity and
mortality for mothers and babies,18-21 and reduction in
the overall rate of intervention in labour is an
international healthcare target.22 23
A possible reason for the higher rate of intervention
in women admitted early is that clinicians do not make
an accurate distinction between women who are in
active labour and those who are not yet in labour or
who are in the latent phase.8-11 This may be because
they misdiagnose active labour or because they use
labour ward admission itself as a proxy measure for
active labour. Once admitted, the mere presence of a
woman in the labour ward over a protracted period of
time may encourage caregivers to intervene.24 Sup-
porting clinicians’ judgments about diagnosis of labour
by providing explicit diagnostic cues has the potential
to reduce unnecessary admissions to the labour ward
and correspondingly the rate of intervention in labour.
Although diagnostic cues for labour have been
described,7 25-31 only one randomised controlled trial
has tested the efficacy of adhering to strict criteria for
diagnosis of labour.30 This study reported a reduction
1Nursing Midwifery and Allied
Health Professions Research Unit,
University of Stirling, Stirling
FK9 4LA
2Department of Health Sciences,
University of York, York YO10 5DD
3Hull York Medical School,
University of York
4Health Economics Research Unit,
Institute of Applied Health
Sciences, University of Aberdeen,
Aberdeen AB25 2ZD
5Department of Nursing and
Midwifery, University of Stirling
6NHS Tayside, Kings Cross
Hospital, Dundee DD3 8EA
Correspondence to: H Cheyne
h.l.cheyne@stir.ac.uk
Cite this as: BMJ 2008;337:a2396
doi:10.1136/bmj.a2396
BMJ | ONLINE FIRST | bmj.com page 1 of 12
 on 10 December 2008 bmj.comDownloaded from 
in the use of augmentation with oxytocin and
analgesics. The study was small, however, and a
Cochrane review concluded that a multicentre rando-
mised controlled trial was needed to determine the
risks and benefits of using explicit criteria to diagnose
active labour.5
The Medical Research Council suggests a frame-
work for developing and evaluating randomised
controlled trials for complex healthcare inter
ventions.32 We followed this framework in conducting
a series of studies to explore the diagnosis of labour
from the perspective of midwives and women and a
needs assessment for an intervention to support mid-
wives’ diagnosis of labour.4 33 34 We chose midwives
because they are the professional group responsible for
the admission of healthy women in labour in the UK.
We chose a decision support approach because
evidence shows that decision aided judgments con-
sistently outperform clinical judgment alone.35 36
Furthermore, the MRC framework stresses the impor-
tance of defining the trial intervention, and this is
particularly important in a trial involvingmultiple sites.
We therefore chose to structure the diagnostic cues for
labour in the formof an algorithm, thus ensuring (as far
as possible) that the intervention would be applied in a
standard fashion across trial sites.
We hypothesised that improving the diagnosis of
labour in primiparous women through the use of an
algorithm would result in a reduction in the use of
oxytocin for augmentation of labour and other labour
interventions compared with standard care. We chose
a cluster randomised trial for this purpose because the
algorithm was aimed at the clinical practice of mid-
wives. We could not use individual randomisation of
women or midwives because of the risk of contamina-
tion between groups. The results of a health economics
evaluation, done as part of the cluster randomised trial,
will be presented elsewhere.
METHODS
Recruitment and randomisation
The trial tookplace betweenApril 2005 and June 2007.
Three levels of participation existed: the unit of
randomisation was the maternity unit, midwives were
participants at the level of the intervention, and we
measured trial outcomes for women receiving mater-
nity care.
Maternity units in Scotland with at least 800 annual
births were eligible to participate in the trial. These
units had the facilities to provide oxytocin for
augmentation of labour.37 After discussion with heads
of midwifery and other stakeholders at each unit,
clinical directors gave consent for trial entry. There-
after, we used minimisation to allocate maternity units
to experimental or control groups.38 After random
allocation of the first maternity unit, we purposively
allocated clusters in order to maximise balance
between groups. We chose presence or absence of an
on-site midwife managed birth unit as the balancing
variable, because the philosophy of care within a
midwife managed birth unit would be one of low
medical intervention and this could correlate with a
lower use of oxytocin. JMB did the group allocation
andwas not involved in recruitment. Study implemen-
tationwas staged to allow time for trainingofmidwives,
with a data collection period of up to 10months in each
maternity unit. A clinical midwife in each unit was
responsible for facilitating study implementation and
collecting trial outcome data from case records.
In the experimental group,we invitedmidwiveswho
admitted women in labour to participate in the study.
We provided workshops and individual contacts for
each midwife, and each received a training manual.
This included informationonhow touse the algorithm,
the cluster trial method, completion of study docu-
mentation, and seeking consent fromwomen in labour.
Thereafter, we asked midwives to consent to study
Study entry criteria
Inclusion criteria
Women presenting for admission in spontaneous labour
and fulfilling the following criteria:
 Primiparous
 Singleton pregnancy
 Cephalic presentation
 37-42 weeks’ gestation
 Current pregnancy uncomplicated
Exclusion criteria
 Girls under 16
 Women with learning difficulties
 Severely ill women
 Women with severe mental illness
 Women with important medical problems:
Essential hypertension
Cardiac disease
Renal disease
Diabetes
Endocrine disease
Epilepsy
History of thromboembolism
Asthma (that is, regular use of inhalers)
Drug or alcohol abuse
 Women with current pregnancy complications:
Haemoglobin <9.0 g/dl
Platelets <100×10/l
Antepartum haemorrhage
Pregnancy induced hypertension
Fetal death
Fetal abnormality
Polyhydramnios >25 cm
Oligohydramnios >5 cm
Current intrauterine growth retardation—that is, less
than 5th centile
Booking weight of 47 kg or less/100 kg or more
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participation. We made minimum contact with mid-
wives in control units to reduce the potential for a
Hawthorne effect.39
We considered women to be eligible for recruitment
if they attended a participating maternity unit for
assessment of labour and were primiparous, at term,
and assessed as low risk on the basis of criteria used in
previous intrapartum studies (box).40-42 We used the
same eligibility criteria in both experimental and
control groups. In order to reduce confounding
variables, we excluded multiparous women from the
trial. Although the principles of diagnosis of labour are
the same for both primiparous and multiparous
women, differences exist in the way in which their
labour would be expected to progress. Furthermore, a
woman’s previous experience of labour will influence
her intrapartum care.
Women in both arms of the trial were given
information at a clinic visit between 34 and 36 weeks’
gestation. Women were required to give consent for
use of the algorithm and collection of identifying data
(needed for distribution of the health economics
questionnaire). However, because the trial inter-
vention was the assessment of labour on admission,
consent had to be obtained differently in experimental
and control groups. In the experimental group, the
admitting midwife identified eligible women on
admission to the labour suite and provided written
and verbal explanations of the study and asked for
consent. This approach could not be used in control
groups without involving labour ward midwives in
providing information about the trial and thus con-
taminating the group, so women in the control group
were asked for consent in the postnatal wards. We
asked midwives to recruit women who would have
been eligible for the trial when they first presented for
labour admission, regardless of subsequent labour
outcome. Although blinding of midwives was not
possible, onlymidwives in the experimental group had
access to the algorithm and minimum information
about the study was available to control units.
Intervention
The process of development and pre-testing of the
algorithm is described elsewhere.33 34 43 The algorithm
comprised three levels: level one confirmed the
woman’s eligibility for involvement in the study (that
is, a healthy primiparous woman with a normal, term
pregnancy); level two prompted a general physical
assessment (for example, temperature, pulse, and
blood pressure); and level three presented, in a
stepwise fashion, key informational cues needed for
diagnosis of labour.Active labourwas diagnosedwhen
painful, regular, moderate or strong uterine contrac-
tions were present (on the basis of the midwives’
clinical assessments), as well as at least one of the
following cues: cervix effacing and at least 3 cmdilated,
spontaneous rupture of membranes, or “show.” We
rigorously pre-tested the algorithm with three samples
of midwives by using questionnaires and vignettes and
found it to have good face validity and content validity
and a high level of inter-rater reliability.43 Subse-
quently, we did a feasibility study in two maternity
units. This showed that the implementation strategy
and methods for the cluster randomised trial were
feasible and acceptable to midwives and women.34
Midwives reported that the algorithm was acceptable
and potentially useful, particularly for inexperienced
midwives.
Context
All units that participated in the trial were consultant
led maternity units with a range of neonatal facilities
(table 1), as classified by the report of the expert group
on acute maternity services in Scotland. 37 The
predominant model of care in all of these units
encouraged women to contact their maternity unit,
by telephone, for advice when they thought that they
were in labour and then to attend thematernity unit for
admission assessment. In all of the units the labour
assessment for most women was done in either the
labour ward or a designated assessment area. During
the trial, women in both groups contacted the hospital
and then attended for assessment in a similar way.
Trial groups
Experimental—In the experimental group, we asked
midwives to use the algorithm during the admission
assessment of women to assist in the diagnosis of active
labour, recording their judgmenton the algorithm.The
algorithm was printed on duplicate paper; once
completed, one part was retained in the woman’s
case record and the other was collected by the local
study coordinator. Women identified as not yet in
active labour were encouraged to return home or were
admitted to an antenatal area, depending on local
maternity unit policy.
Clusters declined to participate (n=1)
Eligible clusters (maternity units) approached (n=15)
Clusters allocated to study group (n=14)
Experimental (n=7)
Baseline data
Control (n=7)
Post-
intervention
Post-
intervention
data analysis
Median cluster size 162
(range 48-202); 1029 women
Median cluster size 114
(range 57-200); 896 women
Eligible midwives
(n=307)
Women lost to
follow-up (n=4)
Women lost to
follow-up (n=8)
Median cluster size 200
(range 81-200); 1287 women
Clinical data analysed (n=892) 80% consented (n=248) Clinical data analysed (n=1279)
Median cluster size 199
(range 96-201); 1291 women
Fig 1 | Trial profile.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 12
 on 10 December 2008 bmj.comDownloaded from 
Control—Eligible women who attended for admis-
sion assessment in the control group units received
normal care. This comprised admission assessment by
midwives using clinical judgment alone. Although
standard care varied between control units, none had
guidelines or protocols for diagnosis of labour at the
time of this study. Owing to the Scotland-wide,
multisite nature of the trial, dictating where the
woman should go after the admission assessment was
not appropriate. Some units served remote and rural
areas, in which women may have travelled for several
hours to reach thematernityunit. In such cases,women
may have had difficulty returning home. Therefore,
after the admission assessment, women in both groups
received standard care for their maternity unit.
Outcomes
The primary outcome was use of oxytocin (any dose)
for augmentation of labour.Women who are admitted
during the latent phase of labour are more likely to be
diagnosed as having slow progress in labour.8-11 We
choseoxytocin as theprimaryoutcomebecause it is the
principal treatment (and key marker) of slow progress
in labour. Furthermore, primiparous women who
receive oxytocin have a reduced likelihood of an
unassisted vaginal delivery.44 The use of explicit
criteria for admission in labour has been associated
with a significant reduction in use of oxytocin in
labour.5 Secondary outcomes were interventions in
labour (artificial rupture of membranes, vaginal
examination, continuous electronic fetal monitoring,
and use of analgesia), admissionmanagement (number
of admissions before labour, time spent in labourward,
and duration of active labour), and labour outcomes
(mode of delivery, intrapartum complications, neona-
tal outcome, and unplanned out of hospital births).
Data collection
Wecollected studyoutcomedata froma sample of case
records at baseline and a second sample after
implementation of the study. We collected baseline
data retrospectively from the case records of 200
women who gave birth in each unit before implemen-
tation of the study and who fitted the trial eligibility
criteria on first labour ward assessment. These data
were anonymised. We collected data for the post-
implementation sample from case records after deliv-
ery.
A secretarybased in the researchunit entered all data
and monitored returns to ensure that recruitment was
meeting agreed milestones. We audited data forms
(10%) and found 88% accuracy of data entry; 12% of
cases had one data entry error, which was corrected.
We established an independent data and safety
monitoring committee to monitor the occurrence of
severe adverse incidents relating to the study. No such
incidents occurred.
Sample size
The statistical power calculationwas appropriate for an
unmatched cluster randomised design. The feasibility
study showed the rate of oxytocin use in primiparous
women in spontaneous labour to be more than 40% in
several units in Scotland, with a mean of 34%. We
calculated the intracluster correlation coefficient to be
0.041. The multidisciplinary trial steering group
deemed a difference of 10 percentage points (for
example, from 40% to 30%) in the proportion of
women receiving oxytocin to be clinically relevant.
Because only a maximum of 15 maternity units were
available, simply comparing intervention and control
groups could not achieve sufficient power to detect this
difference. We therefore used baseline data for the
maternity unit to reduce the effect of variation between
units. We noted the proportion of women given
oxytocin before and after study implementation and
used the proportion before implementation as a
covariate in an analysis at the level of the maternity
unit. From the feasibility study data the study
Table 1 | Characteristics of participating units by cluster*
Unit No
Total annual
births
Birth
unit Unit type*
Labour suite
midwives
Midwives’
consent (%)
Experimental (n=19 410)
2 3166 No 11c 30 102† (100)
4 1305 No 11c 48 31 (65)
7 3324 Yes 11c 27 Missing data
9 1888 No 11c 33 31 (94)
10 950 No 11b 39 25 (64)
12 5242 Yes 111 61 35 (57)
14 3535 No 111 26 24 (92)
Control (n=20 682)
1 1042 No 11b NA NA
3 2988 No 11c NA NA
5 4183 Yes 111 NA NA
6 3426 No 111 NA NA
8 3590 No 11c NA NA
11 2710 Yes 11c NA NA
13 2743 No 11c NA NA
NA=not applicable.
*11b=consultant led maternity unit with on-site special care baby unit and annual births <1000; 11c=consultant
led maternity unit with easy access to neonatal intensive care, adult high dependency, and adult intensive care
and annual births 1000-3000; 111=consultant led specialist maternity unit with on-site neonatal intensive care,
access to adult intensive care, and annual births >3000.
†Recruitment seems to exceed total number of midwives in one cluster because team model of midwifery care
was operating in that unit; this meant that most hospital and community based midwives had labour suite
commitment during study period.
Oxytocin before implementation (%)
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Fig 2 | Oxytocin use before and after trial implementation
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statistician (JMB) estimated that the correlation
between proportions would be 0.89, by using data for
200womenbefore and200 after implementation of the
study in each unit.We used these estimates in the Stata
8 sampsi command to estimate a study power of 0.97
for detecting a 10 percentage point difference in
oxytocin use at a significance level of 0.05 “after”
oxytocin use, with a total of at least 12 hospitals with
200 women observed before and 200 after the trial
implementation point.
Analysis
Data analysis was appropriate for a cluster randomised
trial and accounted for clustering of observations
within maternity units. In practice, a woman may
receive care from several midwives, so we did all
analysis at the level of the unit or the woman. The
primary analysis usedmultiple regression of maternity
unit level data adjusted for baseline.Thismeant that for
each outcome we calculated a summary statistic (the
mean or proportion) for each cluster, at baseline and
after study implementation. In each case, the baseline
value was the covariate. This provided a confidence
interval and test of significance for the difference in
proportions of women receiving oxytocin. We did
other analyses at the level of the individual woman or
using data aggregated to cluster level as appropriate.
RESULTS
Of the 16 eligible maternity units in Scotland, one had
participated in the feasibility study.Weapproached the
remaining 15 units, of which 14 agreed to participate
and were allocated to experimental or control groups.
One unit declined because of other research commit-
ments (fig 1).Once entered, all units completed the trial
as allocated. Table 1 gives a description of the units.
Most units in both groups were classified as 11c on the
basis of the classification of the expert group on acute
maternity services in Scotland,37 and annual births
ranged from 950 to 5242. Two units in each group had
an on-sitemidwifemanaged birth unit.Overall, 80%of
midwives consented to participate (unit range 57-
100%). Baseline datawere collected for 1029women in
the experimental groupand1291women in the control
group (fig 1).
The steering group did a routine review of study
procedures after the first fewmonths of data collection
and recommended a protocol change to minimise any
potential risk of selection bias in the control group.
Midwives might have been reluctant to approach
women who had experienced complications of labour
or negative outcomes. We asked midwives in the
control group to continue to recruit women as planned
up to a sample of 100 women, needed for the health
economics evaluation questionnaire. We asked them
to then go back to the recruitment start date and review
the case records of women who had given birth from
that time and who had been eligible but not recruited.
Anonymous study outcome data were collected from
consecutive cases up to the total target sample of 200
cases. This resulted in near complete data collection in
control units. This strategy was not needed in experi-
mental sites, where all women were recruited prospec-
tively on admission to labour suites. The second
sample, recruited after implementation of the study,
comprised 896 women from experimental units and
1287 cases from the control units (these cases
comprised women who consented postnatally and the
anonymously collected data). A small amount of
information was lost to follow-up from the post-
implementation sample owing to inability to retrieve
case records (four in the experimental group and eight
in the control group) (fig 1). We thus analysed data for
892 women in the experimental group and 1279
women in the control group.
Table 2 shows the flow of data by cluster. We
estimated the number of potentially available women
from routinely collected national data. 45 46 This gives
the number of women who would have been poten-
tially eligible for recruitment during the planned
10 month data collection period after implementation
of the trial in each cluster. The Information Services
Division of NHS National Services Scotland provides
nationaldatabyhealthboardarea, so local variations in
maternity activity are included. The smallest units (in
terms of annual births) did not necessarily have the
fewest number of womenwhowere potentially eligible
for the trial. We asked units to recruit 200 women after
implementation of the trial, but only nine units
managed this. Although the data on potentially eligible
women are estimates, they suggest that the smallest
units experienced difficulty in recruiting the target
sample within the trial period.
Table 3 shows cluster level data for the primary
outcome. Figure 2 shows the proportion of women
given oxytocin for augmentation of labour in each
cluster at baseline and post-implementation.We found
Table 2 | Flow of data by cluster
Unit No
Estimated
availablewomen in
10 months
Baseline
data
(target 200)
After study
implementation
(target 200)
After study
implementation data
analysed
Experimental
2 642 198 200 200
4 138 48 65 64
7 731 83 57 56
9 355 202 200 199
10 156 200 60 60
12 578 162 200 200
14 550 136 114 113
Total 3150 1029 896 892
Control
1 248 201 200 200
3 402 199 200 199
5 842 199 200 200
6 348 200 200 200
8 769 199 200 200
11 538 197 200 200
13 555 96 81 80
Total 3702 1291 1287 1279
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no significant difference in the percentage of oxytocin
use attributable to the application of the algorithm
(difference=0.3, 95% confidence interval −9.2 to 9.8;
P=0.9).
For secondary outcomes, we present summary
descriptive data for experimental and control groups
at baseline (before) and post-intervention (after): these
data do not take account of the effect of clustering. We
then used regression to analyse data for each outcome,
takingaccountof clustering.Weadjusted thedifference
between groups (experimental minus control) for
baseline and clustering. We found no significant
difference between groups for any of the labour
interventions considered: artificial rupture of mem-
branes, continuous electronic fetal monitoring, use of
pain relief, and vaginal examination (table 4).
Significantly more women in the control group had
only one admission (table 5), meaning that women in
the control group were more likely to remain in the
labour suite after their first admission assessment until
delivery. Incontrast,women in theexperimental group
were significantly more likely to have several admis-
sions and discharges before their eventual admission
leading to delivery.
We found no significant difference between groups
for duration of active labour, time from the first labour
assessment to delivery, or time from final admission to
labour suite until delivery (table 6). Themeanduration
of active labour exceeded the mean time from
admission to delivery because active labour started
before admission in several cases. Table 7 shows
additional descriptive data on mean time from final
admission to delivery and duration of active labour by
the number of admissions before labour. We did no
statistical analysis, as the number of previous admis-
sions was an outcome variable.
We found no significant difference in mode of
delivery between study groups (table 8). Overall,
45% (n=2028) of women had at least one intrapartum
complication. We made statistical comparisons only
for complications that occurred in at least 100 cases, as
with fewer cases we could not allow for clustering. We
found no significant difference in maternal complica-
tions between groups.
Table 9 shows neonatal outcomes. Overall, 67
babieswere admitted to theneonatal unit formore than
48 hours, but this did not differ significantly between
groups. Very few unplanned out of hospital births or
babies with an Apgar score less than 7 at five minutes
occurred, so we did no statistical analysis for these
variables. One stillbirth occurred in the control group
at baseline.
DISCUSSION
This trial, involving 14 maternity units and 4503
women, tested the effectiveness of analgorithmtoassist
midwives with the diagnosis of active labour in
primiparous women. We found that use of the
algorithm did not reduce the number of women who
received oxytocin or other medical interventions
compared with standard care. Significantly more
women in the control group remained in the labour
ward until delivery after their first admission, whereas
women in the experimental group were more likely to
be discharged home and subsequently have signifi-
cantly more admissions before labour. We found no
significant difference between groups in the length of
time from the first labour ward assessment until
delivery, time spent in the labour suite during labour,
or duration of active labour. No significant difference
existed between groups for maternal or neonatal
complications or unplanned out of hospital births.
Although we found no significant difference in the
primary outcome, the strength of the study design
Table 3 | Oxytocin use “before” and “after” study implementation
Unit No
Total women per cluster
(before and after)
Oxytocin use—% (No)
At baseline After study implementation
Experimental (n=1921)
2 398 18 (36/198) 41 (82/200)
4 112 33 (16/48) 31 (20/64)
7 139 19 (16/83) 14 (8/56)
9 401 40 (81/202) 34 (67/199)
10 260 37 (73/200) 33 (20/60)
12 362 35 (56/162) 53 (105/200)
14 249 33 (45/136) 36 (41/113)
Control (n=2570)
1 401 35 (70/201) 36 (71/200)
3 398 48 (95/199) 48 (96/199)
5 399 29 (58/199) 30 (60/200)
6 400 37 (74/200) 41 (82/200)
8 399 30 (60/199) 35 (69/200)
11 397 20 (39/197) 36 (72/200)
13 176 34 (33/96) 43 (34/80)
Table 4 | Interventions in labour. Values are numbers (percentages) unless stated otherwise
Intervention
Experimental Control
Difference* (95% CI) P valueBefore (n=1029) After (n=892) Before (n=1291) After (n=1279)
Artificial rupture of membranes 383 (37.2) 401 (44.9) 514 (39.8) 500 (39.0) 5.6 (−2.2 to 13.4) 0.1
Continuous electronic fetal monitor 567 (55.1) 557 (62.4) 781 (60.4) 820 (64.1) −0.1 (−14.2 to 14.1) 1.0
Epidural 211 (20.5) 290 (32.5) 382 (29.5) 441 (34.4) 2.1 (−8.0 to 12.2) 0.7
Opiate 646 (62.7) 532 (59.6) 680 (52.6) 649 (50.7) 1.5 (−4.6 to 7.6) 0.6
Epidural and opiate 129 (12.5) 177 (19.8) 223 (17.2) 225 (17.5) 4.4 (−2.8 to 11.7) 0.2
Vaginal examination mean (range) 2.89 (0-11) 3.67 (0-11) 3.31 (0-10) 3.46 (0-11) 0.2 (−0.3 to 0.7) 0.3
*Data analysis took into account clustering and adjusted for baseline.
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means that it makes an important contribution to the
debate on early labour management. The diagnosis of
labourhas important clinical and resource implications
for the care of a woman in labour, but only one other
trial has specifically evaluated theefficacyofusing strict
diagnostic criteria.30 In contrast to our findings, this
trial reported that when labour was assessed by using
strict diagnostic criteria significantly fewer women
received oxytocin to augment labour (22.9% v 40.4%)
compared with no labour assessment and less pain
relief was used (7.6% v 20%). Although both trials
included similar diagnostic criteria, the interventions
were not identical. In the study by McNiven et al, low
risk women were randomly allocated when they
presented in spontaneous labour.30 All women in the
control group were admitted directly to the labour
ward without assessment of labour, whereas women in
the experimental group had their labour assessed with
strict criteria; those judgednot to be in labourwere sent
home or remained in an assessment area to await the
establishment of active labourbefore being admitted to
the labour ward. McNiven et al thus evaluated a
package of care that included both diagnosis and
management of early labour.30 In the trial reported
here, midwives in both experimental and control
groups carried out a clinical assessment of women
before admission to the labour suite. In the experi-
mental group this assessment was supported by the
algorithm. In both groups, decisions about subsequent
clinical management were determined by the mid-
wives (women could be admitted or discharged home).
Therefore, the groups differed only in the use of the
algorithm; this may have contributed to the difference
in findings compared with those of McNiven et al.30
The principal difference between the studies is,
however, in design and scale. McNiven et al’s study
took place in one hospital with 209 women and was
underpowered to test the effects of the intervention on
several important maternal and neonatal outcomes.30
As our study included 14 maternity units and data on
4503 women, the results are more likely to be an
accurate estimate of the effect of using explicit
diagnostic cues for active labour on the rate of oxytocin
use.
This highlights the importance of both study power
and design. Although the target recruitment of 12
maternity units with an overall target sample of 400 in
each unit (200 before and 200 after implementation of
the trial) was not achieved at all sites, this deficit was
partially offset by the recruitment of an additional two
maternity units. The use of baseline data to reduce the
in-hospital variation was a methodological develop-
ment in this trial. The correlation between the
percentage of women receiving oxytocin before and
after the intervention was 0.46, which was less than the
0.89 originally estimated from data collected during
the feasibility study and this reduced the power of the
study (changeswithin theunitsmayhaveoccurredover
time and reduced the correlation). Nevertheless,
reflecting with hindsight on the success of this method
we can conclude that the study had sufficient power to
test the primary outcome; the 95% confidence interval
for the difference in percentage use of oxytocin was
−9.2 to 9.8, which excludes the difference of 10
percentage points we had chosen as the difference
that would be of clinical relevance.
Table 5 | Number of admissions. Values are numbers (percentages) unless stated otherwise
Admissions
Experimental Control
Difference P valueBefore (n=1029) After (n=892) Before (n=1291) After (n=1279)
One admission 617 (60.0) 398 (44.6) 798 (61.8) 795 (62.6) −19.2 (−29.9 to −8.6) 0.002
Mean (range) admissions 1.28 (1-4) 1.45 (1-4) 1.26 (1-4) 1.28 (1-6) 0.29 (0.04 to 0.55) 0.03
No of admissions before labour:
1 308 (29.9) 305 (34.1) 382 (29.5) 366 (28.6) NA NA
2 79 (7.6) 149 (16.7) 85 (6.5) 88 (6.8) NA NA
3 14 (1.3) 32 (3.5) 16 (1.2) 17 (1.3) NA NA
≥4 2 (0.01) 3 (0.3) 3 (0.2) 3 (0.2) NA NA
Missing data 9 5 7 10 NA NA
NA=not applicable.
Table 6 | Time in labour ward and duration of active labour. Values are mean (SD) unless stated otherwise
Time in labour (hours)
Experimental Control
Difference P valueBefore (n=1029) After (n=892) Before (n=1291) After (n=1279)
Admission to delivery 8.08 (5.68) 9.60 (11.29) 7.81 (5.07) 8.06 (5.41) 0.75 (−0.55 to 2.05) 0.2
Missing data (No) 109 51 98 77
Duration of active labour 9.91 (5.35) 10.82 (5.52) 9.55 (4.96) 9.54 (5.17) 0.61 (−0.45 to 1.67) 0.2
Missing data (No) 145 69 112 98
Time from first admissionassessment todelivery 30.2 (115.0) 29.3 (97.5) 34.7 (154.2) 33.3 (152.3) −0.1 (−14.2 to 14.0) 0.988
Missing data (No) 79 37 70 62
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The fact that this is the first adequately powered
study to assess the impact of diagnostic cues in early
labour management is in itself a success. Healthcare
professionals need robust evidenceonwhich todraw in
making decisions about clinical care. Studies of
complex interventions that are then tested in complex
care systemsare challenging,particularlywhenamulti-
site trial is needed. We followed the MRC framework
for the development of randomised controlled trials of
complex healthcare interventions, doing a series of
pilot and feasibility studies before the cluster trial
reported here. However, the science of trial develop-
ment for complex interventions is constantly changing;
since the inception of this trial, the importance of
carrying out process evaluations concurrently within
the trial itself (rather than in the development stages of
the trial as in this study) has been recognised.47 Such an
evaluation may have provided an explanation of the
findingofnodifferencebetweengroups for theprimary
outcome. It is a characteristic of complex systems (such
asmaternity units) that even a simple interventionmay
have unpredictable effects on the processes and
outcomes of care.48 Therefore, the act of doing a
process evaluation during the course of a trial may in
itself alter practice, thus confounding the results of the
study. These factors need careful consideration during
the design stages of trials of complex interventions.
Limitations of the trial
We could not accurately determine the number of
eligible women in each maternity unit, and estimates
were based on routinely collected data (table 2). These
data were available by hospital, for primiparous
women at term, with a singleton pregnancy, in
spontaneous labour, and over 16 years. However, we
could not identify the number of women who would
have been ineligible for medical or obstetric reasons,
nor could we differentiate between women who were
not eligible and those who were not approached for
consent to data collection. During the feasibility study,
85% of women approached gave consent, so women
not includedwere probably not approached.Although
almost all eligible women in some of the smaller units
seemed to have been included, in most of the units the
proportion of eligible women not included was high
and therefore selection bias could have occurred. The
strength of the cluster design is that it avoids
contamination between groups; however, the design
is prone to selection bias, 49 because consent to trial
entry is given at cluster level but individuals can then
decide whether to accept or refuse the trial inter-
vention. Selection bias is also a common problem in
trials of intrapartum care, in which difficulty in
estimating numbers of potentially eligible participants
and high losses to recruitment are often reported.50
Intrapartum trials often rely on clinical staff to seek
consent fromwomenwho are in labour.Thismethod is
practical in recruitingwomenclose to thepoint of study
intervention, but recruitment is vulnerable to practi-
tioners both making clinical judgments about which
women to approach and forgetting about the trial in the
midst of a busy labour suite.
In the experimental group,midwives sought consent
from women on admission to the labour suite; this is
clearly an emotional time at which to seek consent.
However, as this trial sought to include only women
Table 7 | Length of labour (hours) by number of admissions before labour. Values are mean (SD) unless stated otherwise
Experimental Control
Before (n=1029) After (n=892) Before (n=1291) After (n=1279)
Admission to delivery
Previous admissions:
0 7.72 (5.09) 9.61 (6.02) 7.30 (5.01) 7.81 (5.43)
1 8.50 (5.81) 8.50 (5.42) 8.57 (5.07) 8.38 (5.30)
2 8.46 (4.83) 11.52 (23.77) 9.92 (4.84) 8.55 (5.36)
3 13.00 (14.55) 9.57 (3.95) 8.11 (5.07) 10.46 (6.61)
4 0 11.82 (11.65) 4.45 (2.99) 12.24 (3.83)
5 0 0 0 0
6 0 0 0 12.90*
Missing data 109 51 98 77
Duration of active labour
Previous admissions:
0 9.74 (5.10) 11.31 (5.67) 9.19 (4.88) 9.50 (5.14)
1 10.37 (5.77) 10.47 (5.69) 9.93 (5.06) 9.31 (4.97)
2 9.67 (5.69) 10.10 (4.73) 11.46 (4.75) 10.32 (6.12)
3 9.34 (6.20) 11.67 (5.25) 10.79 (5.45) 11.06 (5.00)
4 0 6.15 (2.7) 10.76 (4.48) 14.61 (2.23)
5 0 0 0 0
6 0 0 0 12.90*
Missing data 145 69 112 98
*One woman only.
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with a normal healthy pregnancy, those women who
were particularly vulnerable due to identifiable med-
ical or obstetric risk factors for mother or baby were
excluded. Midwives may have deemed it inappropri-
ate to approach women who presented in advanced
labour (this has been reported in other intrapartum
studies42). A systematic bias in the experimental group
towards recruiting women admitted in early labour
would have resulted in a longer time period between
the first labour assessment and delivery in that group.
However, we found no significant difference between
the groups in this respect, which suggests that no
systematic selection occurred in favour of women in
early labour in the experimental group.
Our aim was that the trial would have minimal
impact in the control units, so no member of staff was
given access to the algorithmandno information about
the trial was introduced to labour suite midwives.
Although we could not recruit women in the control
group in the samewayas in the experimental group,we
used the same trial entry criteria. We maximised the
use of anonymised data after the protocol change, to
minimise the potential for Hawthorne effects and
reduce selection bias.
The admission of women in labour is part of routine
midwifery practice, and midwives in both groups
probably used the same or similar criteria for diagnosis
of labour (we developed the algorithm in consultation
withmidwives). However, the structuring of these cues
in a linear decision rule comprised the intervention
tested in this trial. Studies of decision support suggest
that it is the consistency of decision support tools, not
Table 8 | Maternal outcomes. Values are numbers (percentages) unless stated otherwise
Outcomes
Experimental Control
Difference P value
Before
(n=1029)
After
(n=892)
Before
(n=1291)
After
(n=1279)
Mode of delivery
Spontaneous vertex delivery 709 (68.9) 526 (58.9) 810 (63) 785 (61.3) −3.2 (−15.1 to 8.7) 0.6
Breech 3 (0.2) 0 0 0 NA NA
Instrumental 205 (19.9) 241 (27.0) 319 (25) 323 (25.2) NA NA
Elective caesarean section 4 (0.3) 0 0 3 NA NA
Emergency caesarean section 106 (10.3) 123 (13.7) 162 (12.5) 165 (12.9) 0.0 (−4.3 to 4.3) 1.0
Missing data 2 2 0 3 NA NA
Complications
Any complication 422 (41) 439 (49.2) 571 (44.2) 596 (46.6) 3.9 (−9.4 to 17.2) 0.5
Failure to progress—first stage 70 (6.8) 42 (4.7) 55 (4.3) 59 (4.6) −3.4 (−15.3 to 8.6) 0.5
Failure to progress—second stage 91(8.8) 142 (15.9) 84 (6.5) 119 (9.3) 15.2 (−4.5 to 34.9) 0.1
Mal position/presentation 11 (1.1) 9 (1.0) 10 (0.8) 16 (1.2) NA NA
Intrapartum haemorrhage 10 (1.0) 5 (0.5) 6 (0.5) 7 (0.5) NA NA
Postpartum haemorrhage 12 (1.2) 10 (1.1) 16 (1.2) 20 (1.5) NA NA
Failed forceps 4 (0.4) 9 (1.0) 1 (0.1) 3 (0.2) NA NA
Shoulder dystocia 4 (0.4) 5 (0.5) 13 (1.0) 7 (0.5) NA NA
Maternal pyrexia 2 (0.2) 3 (0.3) 12 (0.9) 10 (0.7) NA NA
Raised blood pressure 5 (0.5) 4 (0.4) 5 (0.4) 6 (0.4) NA NA
Retained placenta 11 (1.1) 16 (1.7) 26 (2.0) 14 (1.0) NA NA
Third/fourth degree tear 8 (0.8) 7 (0.7) 10 (0.8) 8 (0.6) NA NA
NA=not applicable.
Table 9 | Neonatal indicators and outcomes. Values are numbers (percentages) unless stated otherwise
Indicator/outcome
Experimental Control
Difference P valueBefore (n=1029) After (n=892) Before (n=1291) After (n=1279)
In labour:
Fetal distress 152 (14.7) 166 (18.6) 245 (19.0) 242 (18.9) 2.4 (−6.6 to 11.3) 0.6
Meconium stained liquor 152 (14.8) 133 (14.9) 213 (16.5) 211 (16.6) −0.5 (−7.2 to 6.3) 0.9
Mean (SD) Apgar:
At 1 minute 9.52 (10.2) 8.84 (6.9) 8.97 (7.24) 9.21 (8.85) 0.00 (−0.17 to 0.15) 0.9
At 5 minutes 9.25 (0.70) 9.27 (0.79) 9.10 (0.74) 9.14 (0.69) −0.08 (−0.27 to 0.11) 0.4
Apgar <7 at 5 minutes* 7 (0.6) 9 (1.0) 18 (1.3) 13 (1.0) – –
Resuscitation 130 (14.0) 106 (12.7) 151 (12.0) 145 (11.6) −0.9 (−6.4 to 4.7) 0.7
Missing data 101 58 29 29
Admitted to neonatal unit 38 (3.6) 29 (3.2) 56 (4.3) 60 (4.6) −0.4 (−2.6 to 1.8) 0.7
Unplanned out of hospital birth* 6 (0.5) 11 (1.2) 9 (0.6) 11 (0.8) – –
*Numbers too small for inferential statistical analysis.
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the provision of new knowledge, that makes them
effective.51 52 However, the reluctance of healthcare
professionals to use decision support has been widely
reported in other studies.35 36 53 54 For example, a study
of a decision support tool that reduced the rate of false
positive diagnosis of acute ischaemic heart disease
from 71% to 0% found that the subsequent use of the
tool by clinicians was only 2.8%.55 Several possible
reasons have been suggested—in particular, that
decision support mediates against individuality of
care and that it undermines the skills of the
practitioner.56-58 Use of decision support tools has
also been suggested to undermine the clinical cred-
ibility of practitioners. Arkes et al found that the
diagnostic ability of doctors who used decision support
was rated (by students) as lower than that of those who
used clinical judgment alone.59 We assessed the
acceptability of the algorithm to midwives during the
feasibility study, in which midwives reported will-
ingness to use the algorithm. In the cluster randomised
trial, the rate of consent of midwives to use the
algorithm varied between units from 57% to 100%. In
most (although not all) units, this consent rate reflected
the success or otherwise of subsequent data collection.
Although an algorithm was completed for each
woman, and this gives an indication of compliance
with the protocol, midwives could have disregarded its
recommendation in deciding whether to admit or
discharge women. Studies of how nurses use compu-
terised decision support tools indicate that such tools
are often completed after the nurse hasmade adecision
about the care that a patient should receive,60-63 and this
may have contributed to the finding of no difference in
the primary outcome. We found evidence that using
the algorithm did alter the midwives’ judgments, as
women in the experimental group were significantly
more likely to be discharged after their first labour
assessment than were women in the control group.
However, these women quickly returned to the
hospital, creating a “revolving door” effect. This
implies that the observation from other studies of
higher rates of intervention in women admitted to
labour suites early cannot be fully explained by a
failure of clinicians to distinguish between the latent
and active phases of labour.
Recommendations and future directions
Admission of women who are not in active labour is a
considerable problem leading to higher levels of
medical intervention than for those admitted in active
labour.Maternity service guidelines advocate advising
women to remain at home or to return home until
labour is established, but thismay be an over-simplistic
approach that does not meet the needs of women in
early labour.Wedesigned thealgorithmto support one
aspect of theprocess of themanagement of early labour
(the diagnosis). The fact that this has not translated into
a change in clinical outcomes probably reflects the
complexity of management decisions for women in
labour, which are influenced by factors such as how a
woman is coping with pain and the level of social
support available. Studies of women’s experience of
early labour have found that women in their first
pregnancy report feeling unprepared for the latent
phase of labour and that their experience is char-
acterised by pain and anxiety.4 64 Women seek
reassurance from hospital admission; although some
receive this reassurance, others report feeling that their
needs (in particular for pain relief) were not met. Our
findings suggest that although the algorithm has the
potential to reduce admissions of women not in active
labour, merely sending these women home did not
produce a clinical benefit. Indeed, it may have
contributed to negative experiences for these women.
Analysis of postnatal questionnaire data (which will be
reported in a separate paper), obtained by use of a
discrete choice experiment method, suggested that
womenhad apositivepreference for being admittedon
initial presentation, as opposed to being discharged
home on two or three occasions.
Conclusions
Use of an algorithm for diagnosis of active labour in
primiparous women did not result in a reduction in
oxytocin use or medical intervention in spontaneous
labour. More women in the experimental group were
discharged home after their first labour ward assess-
ment. Diagnosis of labour is an important clinical
judgment.However, subsequent decisionsmade about
the management of women found to be not yet in
labour, or who are in the latent phase, may be themost
important anddifficult decisions in the care of awoman
in labour. Research that includes both women’s and
clinicians’ perspectives about management of early
labour is now needed.
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